BriaCell Therapeutics Corp. Common Shares (NASDAQ: BCTX) last traded at $3.87, down 1.28% on the session. The quote above updates while this page is open; the figures below are drawn from BriaCell Therapeutics Corp. Common Shares’s own filings and are restated only when a new one is published.
BriaCell Therapeutics Corp. Common Shares trades on NASDAQ under the ticker BCTX. Its market capitalisation is $33.67 million.
Valuation measures for BriaCell Therapeutics Corp. Common Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $33.67M |
|---|---|
| Enterprise value | $30.45M |
| Price / book | 1.44 |
| Beta | 1.86 |
Trailing-twelve-month figures tagged in BriaCell Therapeutics Corp. Common Shares's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$30.68M |
| Return on equity | -131.04% |
|---|
| Cash | $6.88M |
|---|
Range and volume for BCTX over the past 52 weeks.
| 52-week high | $14.68 |
|---|---|
| 52-week low | $2.60 |
| Volume | 23.8K |
| Average volume | 270.5K |
| Previous close | $3.92 |
Invest a chosen dollar amount in BriaCell Therapeutics Corp. Common Shares with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell BCTX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.